Total Payments
$8,140
2024 Payments
$939.11
Companies
58
Transactions
296
Medicare Patients
3,742
Medicare Billing
$394,744
Payment Breakdown by Category
Food & Beverage$7,099 (87.2%)
Travel$645.94 (7.9%)
Education$395.07 (4.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,099 | 284 | 87.2% |
| Travel and Lodging | $645.94 | 1 | 7.9% |
| Education | $395.07 | 11 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NeoTract Inc. | $1,589 | 18 | $0 (2020) |
| Astellas Pharma US Inc | $1,300 | 54 | $0 (2024) |
| ABBVIE INC. | $683.83 | 29 | $0 (2024) |
| PFIZER INC. | $426.39 | 20 | $0 (2021) |
| Janssen Biotech, Inc. | $410.00 | 21 | $0 (2022) |
| Dendreon Pharmaceuticals LLC | $292.89 | 14 | $0 (2024) |
| Coloplast Corp | $189.44 | 8 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $187.02 | 4 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $162.35 | 7 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $161.39 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $939.11 | 35 | ABBVIE INC. ($276.98) |
| 2023 | $400.97 | 17 | Sumitomo Pharma America, Inc. ($105.69) |
| 2022 | $575.82 | 24 | ABBVIE INC. ($119.76) |
| 2021 | $328.94 | 13 | Teleflex LLC ($97.50) |
| 2020 | $434.59 | 18 | PFIZER INC. ($158.50) |
| 2019 | $1,702 | 71 | Astellas Pharma US Inc ($325.13) |
| 2018 | $2,653 | 66 | NeoTract Inc. ($1,281) |
| 2017 | $1,105 | 52 | Astellas Pharma US Inc ($455.45) |
All Payment Transactions
296 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/19/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $22.43 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $42.85 | General |
| Category: Urology | ||||||
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.81 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/20/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $28.17 | General |
| 11/18/2024 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $90.00 | General |
| Category: Urology | ||||||
| 10/24/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Oncology | ||||||
| 10/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.95 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/18/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $119.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $19.78 | General |
| Category: Prostate cancer | ||||||
| 10/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.37 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.81 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/19/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 09/14/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Oncology | ||||||
| 08/12/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Oncology | ||||||
| 07/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $1.57 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/06/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $18.93 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $17.57 | General |
| Category: ONCOLOGY | ||||||
| 06/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.34 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/24/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $34.98 | General |
| Category: Oncology | ||||||
| 05/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/01/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Immunotherapy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 892 | 1,236 | $340,519 | $93,010 |
| 2022 | 15 | 1,008 | 1,334 | $410,460 | $112,054 |
| 2021 | 13 | 922 | 1,245 | $304,853 | $94,146 |
| 2020 | 14 | 920 | 1,245 | $326,088 | $95,534 |
Total Patients
3,742
Total Services
5,060
Medicare Billing
$394,744
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 188 | 228 | $82,308 | $21,801 | 26.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 17 | 136 | $54,400 | $18,511 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 146 | 186 | $47,430 | $12,209 | 25.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 58 | 65 | $45,175 | $12,133 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 73 | 73 | $34,310 | $8,861 | 25.8% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 17 | 19 | $21,869 | $6,276 | 28.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 28 | $14,140 | $3,738 | 26.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 245 | 308 | $15,708 | $2,620 | 16.7% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 24 | 80 | $7,680 | $2,245 | 29.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 19 | $7,068 | $2,010 | 28.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 11 | 11 | $6,391 | $1,310 | 20.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 23 | $3,680 | $1,092 | 29.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 51 | 60 | $360.00 | $204.60 | 56.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 193 | 242 | $85,601 | $23,265 | 27.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 16 | 128 | $51,200 | $17,873 | 34.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 62 | 68 | $47,116 | $13,839 | 29.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 113 | 113 | $52,581 | $13,448 | 25.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 154 | 188 | $47,126 | $12,286 | 26.1% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2022 | 18 | 18 | $42,066 | $10,640 | 25.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 38 | 41 | $20,635 | $6,004 | 29.1% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 19 | 19 | $14,972 | $3,224 | 21.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 21 | 21 | $12,201 | $2,563 | 21.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 237 | 306 | $15,606 | $2,497 | 16.0% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Office | 2022 | 13 | 13 | $6,461 | $1,997 | 30.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 18 | $6,692 | $1,963 | 29.3% |
About Dr. Brian Shaffer, MD
Dr. Brian Shaffer, MD is a Urology healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1306986930.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Shaffer, MD has received a total of $8,140 in payments from pharmaceutical and medical device companies, with $939.11 received in 2024. These payments were reported across 296 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($7,099).
As a Medicare-enrolled provider, Shaffer has provided services to 3,742 Medicare beneficiaries, totaling 5,060 services with total Medicare billing of $394,744. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Portland, OR
- Active Since 02/06/2007
- Last Updated 01/03/2011
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1306986930
Products in Payments
- UROLIFT (Device) $1,064
- XTANDI (Drug) $964.55
- UroLift (Device) $466.36
- BOTOX (Biological) $370.43
- Erleada (Drug) $359.00
- PROVENGE (Drug) $308.14
- Myrbetriq (Drug) $200.01
- Xtandi (Drug) $189.51
- ZYTIGA (Drug) $181.35
- ELIGARD (Drug) $167.17
- Xofigo (Drug) $162.35
- Otrexup (Drug) $144.16
- ORGOVYX (Drug) $141.43
- Lupron (Drug) $135.91
- CVAC ASPIRATION SYSTEM (Device) $132.85
- MYRBETRIQ (Drug) $122.72
- FARXIGA (Drug) $119.28
- Urolift - UL400 (Device) $116.39
- NOCDURNA (Drug) $106.51
- 16 FR. FLEXIBLE VIDEO CYSTOSCOPE (Device) $100.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Portland
Dr. Lance Marr, M.d, M.D
Urology — Payments: $277,964
Urology $277,964
Dr. Geolani Dy, M.d, M.D
Urology — Payments: $69,493
Urology $69,493
Jyoti Chouhan, Do, Pharmd, DO, PHARMD
Urology — Payments: $62,636
Urology $62,636
David Sobel, Md, MD
Urology — Payments: $41,221
Urology $41,221
Dr. James Tycast, M.d, M.D
Urology — Payments: $38,374
Urology $38,374
Amir Patel
Urology — Payments: $35,329
Urology $35,329